Biotech Investing Strategy for 2020: Part I…Update-1 Jan 24
Update-1 We remain on hold for taking on new positions. Biotech and healthcare stocks have made nice gains so let's get through the earnings cycle. Markets are jittery despite rush to new highs at opening, S&P 500 down 0.82%, as of mid-day trading over coronavirus concerns in China with 926...
JPM 2020 #3 : Biotechs Sustain Gains for the Week-Trading Up Today…Update-1. Momentum is easing
Momentum is Easing in Biotech -Is the JPMorgan rally Over? We need to see which stocks hold up when momentum decelerates. it has been a good run for the week but not too frothy.We are "content challenged" in that we sat through three days of interesting and informative investment opportunities...
JPM 2020 Notes #2: Investors Catch the Buzz of Life Science Innovation
JPM Notes #2 : Investors buy into Life science innovation After a lackluster day Monday the tape for JPM life science sector stocks picked up with a decent rally. Major ETFs reversed the trend from yesterday with the IBB up 1.64% and the XBI up 2.94% despite NASDAQ being down 0.24%. It was a...
JPM 2020 Notes #1 With NASDAQ Up 1.04% A Good Day For Many Stocks, Despite Losses in IBB and XBI…Update-1
Update-1 1/14/2 12:30 EDT...Very Bullish Tape today--Update at Close IBB up 1.27% , XBI up 2.47%. Gene therapy stocks are on a tear even before BLUE and EDIT (both up >5%) present later today and tomorrow. ===== J.P.Morgan Healthcare Conference Notes #1: Biotech Sectors Lag, IBB down...
Geopolitical Uncertainty Curbs Biotech Stock Gains: Update-1
Update-1 1/9/20 "Sigh of Relief" rally for second day -Don't Fight the FED Dont confuse a momentum rally with fundamental analysis as we are at new highs with market PEs>18. Large cap biiopharmas are at new highs Mid-cap 2%+ winners today: ACAD, ALNY, BMRN, GWPH, MRNA, QURE, NBIX. XBI...